Skip to main content
Clinical Trials/NCT02519361
NCT02519361UnknownNot Applicable

The Involvement of the Translation Initiation Factors eIF4E and eIF4G in Resolution of Inflammation in the Elderly Population

Meir Medical Center0 sites30 target enrollmentStarted: August 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Primary Endpoint
Translation initiation factors expression by immunoblotting, in leukocytes sub population

Study Overview

Brief Summary

Aging cause specific changes in the immune system. Processes like "immunoessence" and "inflammaging" offend the functioning of the immune cells and expose the elderly patient to infections that can lead to morbidity and death.

Protein translation regulation offers a strategic advantage to the immune cells, because it enables rapid activation or termination of synthesis of specific proteins, required for inflammation or its resolution. Translation initiation depends on recruitment of eukaryotic initiation factor "eIF4F" complex.

The aim of the current study is to investigate the involvement of the translation initiation factors (eIF4E and eIF4G) in the process of recovery from acute infection in elderly patient admitted to the internal department with an acute infection.

Detailed Description

  1. Blood samples of elderly patients diagnosed with acute infection (fever and leukocytosis) will be collected twice - at admittance to Meir hospital and after recovery (24-48 hours without fever and leukocytosis). evidence of infection (chest x ray, urine and blood samples) will be collected. participants will be divided to two age groups: 65-80 yrs and very old patient >85 yrs, and will be compared to younger patients aged 50-65.
  2. Peripheral blood samples will be separated to subpopulations of lymphocytes, monocytes and polymorphonuclears, and protein will be extracted.
  3. protein lysates will be separated by SDS-PAGE electrophoresis and immunoblotted for phosphorylated and total eIF4E and eIF4G; their regulators: Mnk 1/2, 4EBP1, mTOR and targets: cyclin D1, c-Myc, survivin, BCL2, VEGFA, etc.
  4. Paired samples (within each age group) will be analyzed and correlated with clinical response of the patients. The source of the infection will also be considered.
  5. Comparison between age groups at admittance and upon recovery will be made (Unpaired).

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
50 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patient aged 50 y and more with:
  • fever >38c that started in the 48 hours prior to admission
  • leukocytosis >10.0 K/microLiter
  • suspected source of infection by symptoms, lab results or imaging
  • treatment with antibiotics started in the last 24 hours or is about to be started

Exclusion Criteria

  • patients who cannot sign the informed concent ( dementia)
  • patients with active malignancy
  • patients who are under chemotherapy

Outcomes

Primary Outcomes

Translation initiation factors expression by immunoblotting, in leukocytes sub population

Time Frame: 1 week

Assessment of eIF4E and eIF4G expression by immunoblotting, in leukocytes sub populations under inflamed conditions and upon resolution of acute inflammation, in three groups of age

Secondary Outcomes

  • Translation initiation factors regulators expression by immunoblotting in leukocytes sub population(1 week)
  • Translation initiation factors targets expression by immunoblotting in leukocytes sub population(1 week)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials